Headlands Technologies LLC Purchases 46,371 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Headlands Technologies LLC increased its shareholding in Option Care Health, Inc. by 299.9%, owning 61,834 shares valued at approximately $2.16 million.
• Institutional investors collectively hold 98.05% of Option Care Health's stock, indicating strong institutional confidence in the company.
• Analysts have a consensus rating of "Moderate Buy" for Option Care Health, with target prices ranging from $35.75 to $40.00, reflecting positive growth expectations.

Headlands Technologies LLC grew its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 299.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 61,834 shares of the company's stock after buying an additional 46,371 shares during the quarter. Headlands Technologies LLC's holdings in Option Care Health were worth $2,161,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in the company. Dimensional Fund Advisors LP increased its position in Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after buying an additional 591,042 shares during the period. Northern Trust Corp increased its position in Option Care Health by 11.8% in the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock worth $60,934,000 after buying an additional 278,158 shares during the period. Charles Schwab Investment Management Inc. increased its position in Option Care Health by 4.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company's stock worth $91,209,000 after buying an additional 99,574 shares during the period. Allspring Global Investments Holdings LLC increased its position in Option Care Health by 6,525,926.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock worth $52,459,000 after buying an additional 1,500,963 shares during the period. Finally, Comerica Bank increased its position in shares of Option Care Health by 13.1% during the fourth quarter. Comerica Bank now owns 1,357,628 shares of the company's stock valued at $31,497,000 after purchasing an additional 157,198 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Trading Down 1.1%

NASDAQ OPCH traded down $0.30 on Monday, reaching $27.90. The company had a trading volume of 396,702 shares, compared to its average volume of 1,842,138. The stock's 50 day moving average is $30.64 and its 200-day moving average is $31.95. The stock has a market cap of $4.53 billion, a price-to-earnings ratio of 22.36, a PEG ratio of 1.78 and a beta of 0.79. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. Option Care Health's quarterly revenue was up 15.4% on a year-over-year basis. During the same period last year, the company earned $0.30 earnings per share. Equities analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on OPCH. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. JMP Securities boosted their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Citigroup reissued an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and an average target price of $35.75.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.